Variant report
Variant | esv2476785 |
---|---|
Chromosome Location | chr7:18249559-18251019 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:5)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr7:18240899..18244580-chr7:18250175..18254118,3 | K562 | blood: | |
2 | chr7:18216226..18218726-chr7:18250746..18252267,2 | K562 | blood: | |
3 | chr7:18240899..18246753-chr7:18248807..18254845,6 | K562 | blood: | |
4 | chr7:18217240..18219162-chr7:18248697..18251214,2 | MCF-7 | breast: | |
5 | chr7:18250651..18253317-chr7:18302876..18305651,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs562685647 | chr7:18249559-18249560 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs190342101 | chr7:18249565-18249566 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs576410640 | chr7:18249580-18249581 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs542297474 | chr7:18249603-18249604 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs559048079 | chr7:18249616-18249617 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs1178385 | chr7:18249619-18249620 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs371923009 | chr7:18249632-18249633 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs34805942 | chr7:18249635-18249636 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs546977562 | chr7:18249683-18249684 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs370914099 | chr7:18249693-18249694 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs141720779 | chr7:18249750-18249751 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs183265270 | chr7:18249777-18249778 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs569087830 | chr7:18249792-18249793 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs150566468 | chr7:18249800-18249801 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs551779110 | chr7:18249812-18249813 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs139587350 | chr7:18249835-18249836 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs533507311 | chr7:18249853-18249854 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs187644010 | chr7:18249916-18249917 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs544643444 | chr7:18249941-18249942 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs375807046 | chr7:18249963-18249964 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs571689629 | chr7:18249998-18249999 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs149792286 | chr7:18249999-18250000 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs531110317 | chr7:18250022-18250023 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs368512963 | chr7:18250023-18250024 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs551300964 | chr7:18250025-18250026 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs147495966 | chr7:18250083-18250084 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs567847520 | chr7:18250087-18250088 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs79171964 | chr7:18250161-18250162 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs577906843 | chr7:18250226-18250227 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs545227555 | chr7:18250232-18250233 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs139863041 | chr7:18250251-18250252 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs560142987 | chr7:18250315-18250316 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs559016524 | chr7:18250327-18250328 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs192751028 | chr7:18250336-18250337 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs540233185 | chr7:18250344-18250345 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs561733257 | chr7:18250407-18250408 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs529277954 | chr7:18250444-18250445 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs76530260 | chr7:18250472-18250473 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs550657348 | chr7:18250473-18250474 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs7779744 | chr7:18250482-18250483 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs184218690 | chr7:18250544-18250545 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs551952988 | chr7:18250567-18250568 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs567025039 | chr7:18250571-18250572 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs147733280 | chr7:18250605-18250606 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs188445593 | chr7:18250618-18250619 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs567245457 | chr7:18250624-18250625 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs192668227 | chr7:18250641-18250642 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs556281901 | chr7:18250645-18250646 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs577818659 | chr7:18250784-18250785 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs538429717 | chr7:18250796-18250797 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Biliary cancer | 19435499 | CNVD |
Cancer | 16751803 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Wilms tumour | 21544195 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Astrocytoma | 17387387 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Glioma | 21971842 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Oral cancer | 21386901 | CNVD |
colon cancer | 17210682 | CNVD |
Lung adenocarcinoma | 21810691 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Hypothalamic hamartomas | 18252217 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Stenocardia | 21860640 | CNVD |
Vasospasm | 21860640 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21364760 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Leukemia | 23979775 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Autism | 22495311 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Prostate cancer | 19242612 | CNVD |
Autism | 18414403 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 21858162 | CNVD |
Pleomorphic liposarcoma | 18784837 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Cancer | 21637783 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Breast cancer | 16397240 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Heart disease | 21282601 | CNVD |
Rubinstein-Taybi syndrome | 22470819 | CNVD |
Alzheimer''s disease | 22166940 | CNVD |
Abnormal phenotypes | 18644119 | CNVD |
Non-syndromic sensorineural hearing loss | 22570644 | CNVD |
Bladder cancer | 21909424 | CNVD |
Cancer | 21183584 | CNVD |
Autism | 20808228 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Bipolar disorder | 19114987 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:18241400-18251200 | Weak transcription | Left Ventricle | heart |
2 | chr7:18242200-18250000 | Weak transcription | Fetal Heart | heart |
3 | chr7:18250000-18252000 | Enhancers | Fetal Heart | heart |
4 | chr7:18250200-18252400 | Enhancers | Monocytes-CD14+_RO01746 | blood |
5 | chr7:18250400-18252400 | Enhancers | Primary monocytes fromperipheralblood | blood |
6 | chr7:18250600-18251000 | Enhancers | Adipose Nuclei | Adipose |
7 | chr7:18250800-18251200 | Enhancers | Fetal Lung | lung |
8 | chr7:18251000-18251800 | Enhancers | Psoas Muscle | Psoas |
9 | chr7:18251000-18252400 | Weak transcription | Adipose Nuclei | Adipose |
10 | chr7:18251000-18253600 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |